Immunological and biochemical responses in mice treated with mercuric chloride.
Adult B6C3F1 male mice were given water containing 3, 15, and 75 ppm mercury (as mercuric chloride) for 7 weeks. There were dose-related increases in blood and kidney mercury levels but only the former showed a time-dependent change. Mercury was not detected in any of the lymphoid organs except for the spleen. There was no mortality and only minimal histological changes occurred in kidneys of dosed mice. Nonspecific toxicity occurred at the 75 ppm dose level, consisting of small differences in body and organ weights, hematological changes, and general enzyme inhibition in the bone marrow and spleen. However, there were specific immunotoxic and biochemical alterations in lymphoid organs of mice treated at the lower doses of mercury. The immunological defects were consistent with altered T-cell function as evidenced by decreases in both T-cell mitogen and mixed leukocyte responses. There was a particular association between the T-cell defects and inhibition of thymic pyruvate kinase, the rate-limiting enzyme for glycolysis. The differences in the pattern of enzyme responses among lymphoid organs implied that two mechanisms of mercury toxicity were operative--one at high concentrations that caused physicochemical enzyme inhibition and another at low concentrations that caused indirect enzyme inhibition.
D000818:Animals; D001769:Blood / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001853:Bone Marrow / Q000201:enzymology; D005947:Glucose / Q000378:metabolism; D007109:Immunity / Q000187:drug effects*; D008297:Male; D008627:Mercuric Chloride; D008628:Mercury / Q000378:metabolism / Q000633:toxicity*; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D013154:Spleen / Q000201:enzymology; D013950:Thymus Gland / Q000201:enzymology; D014018:Tissue Distribution
D008627:Mercuric Chloride; D008628:Mercury; D005947:Glucose